LEXICON PHARMACEUTICALS, INC. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 8, 2010

Attached files

file filename
10-K - FORM 10-K - LEXICON PHARMACEUTICALS, INC.form10k_2009.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - LEXICON PHARMACEUTICALS, INC.exh31_1.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - LEXICON PHARMACEUTICALS, INC.exh31_2.htm
EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICERS - LEXICON PHARMACEUTICALS, INC.exh32_1.htm
EX-10.15 - FORM NON-EMPLOYEE DIRECTOR STOCK OPTION AGREEMENT - LEXICON PHARMACEUTICALS, INC.exh10_15.htm
EX-10.16 - FORM OFFICER STOCK OPTION AGREEMENT - LEXICON PHARMACEUTICALS, INC.exh10_16.htm
 
Exhibit 23.1


Consent of Independent Registered Public Accounting Firm


We consent to the incorporation by reference in the following Registration Statements:

(1)
 
  
Registration Statement (Form S-8 No. 333-41532) pertaining to the Equity Incentive Plan and to the Non-Employee Directors’ Stock Option Plan of Lexicon Pharmaceuticals, Inc.,
 
(2)
 
  
Registration Statement (Form S-8 No. 333-66380) pertaining to the Coelacanth Corporation 1999 Stock Option Plan of Lexicon Pharmaceuticals, Inc.,
 
(3)
 
  
Registration Statement (Form S-3 No. 333-67294) of Lexicon Pharmaceuticals, Inc.,
 
(4)
 
  
Registration Statement (Form S-3 No. 333-108855) of Lexicon Pharmaceuticals, Inc.,
 
(5)
 
  
Registration Statement (Form S-3 No. 333-111821) of Lexicon Pharmaceuticals, Inc.,
 
(6)
 
  
Registration Statement (Form S-3 No. 333-144933) of Lexicon Pharmaceuticals, Inc., and
 
(7)
 
  
Registration Statement (Form S-3 No. 333-161696) of Lexicon Pharmaceuticals, Inc.
 

of our report dated March 5, 2010, with respect to the consolidated financial statements of Lexicon Pharmaceuticals, Inc. incorporated herein by reference, and our report dated March 5, 2010, with respect to the effectiveness of internal control over financial reporting of Lexicon Pharmaceuticals, Inc., included in this annual report of Lexicon Pharmaceuticals, Inc. (Form 10-K) for the year ended December 31, 2009.

 
/s/ ERNST & YOUNG LLP


Houston, Texas
March 5, 2010

LEXICON PHARMACEUTICALS, INC. Reports